Notably, treatment with anti‐Ly6a antibodies enhances antitumor activity by reprogramming mitochondrial metabolism through the ERK/c‐Myc signaling axis.[333] In addition, IL‐15, a cytokine upregulated in skin cells following UVR, exhibits sustained expression during melanoma progression. This evidence concerns the gene IL15 and melanoma.